Activities of Imipenem and Cephalosporins against Clonally Related Strains of Escherichia coli Hyperproducing Chromosomal β-Lactamase and Showing Altered Porin Profiles

ABSTRACT Forty clonally related clinical isolates of Escherichia coli from hospitalized patients were resistant to cefoxitin (MICs, >256 μg/ml) and ceftazidime (MICs, 32 to 256 μg/ml) and were intermediate or resistant to cefotaxime (MICs, 16 to 128 μg/ml) but susceptible to both cefepime (MICs, 0.5 to 2 μg/ml) and imipenem (MICs, 0.125 to 0.25 μg/ml). Resistance to β-lactams was related to high-level production of AmpC β-lactamase and loss of OmpF porin.

[1]  D. Persing,et al.  Diagnostic molecular microbiology. , 2001, Current clinical topics in infectious diseases.

[2]  C. Quentin,et al.  Molecular Characterization of TEM-59 (IRT-17), a Novel Inhibitor-Resistant TEM-Derived β-Lactamase in a Clinical Isolate of Klebsiella oxytoca , 1999, Antimicrobial Agents and Chemotherapy.

[3]  G. Jacoby,et al.  Roles of β-Lactamases and Porins in Activities of Carbapenems and Cephalosporins against Klebsiella pneumoniae , 1999, Antimicrobial Agents and Chemotherapy.

[4]  N. Caroff,et al.  Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production. , 1999, FEMS microbiology letters.

[5]  E. Nelson,et al.  Molecular Basis of AmpC Hyperproduction in Clinical Isolates of Escherichia coli , 1999, Antimicrobial Agents and Chemotherapy.

[6]  A. Dalhoff.  Fourth-Generation Cephalosporins , 1998 .

[7]  J. Fung-Tomc.  Fourth-generation cephalosporins , 1997 .

[8]  K. Bush,et al.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein , 1997, Antimicrobial agents and chemotherapy.

[9]  J. Tenney,et al.  Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Fosberry,et al.  Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta-lactamase gene in Escherichia coli BS , 1994, Antimicrobial Agents and Chemotherapy.

[11]  J. Chow,et al.  Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. , 1991, The Journal of antimicrobial chemotherapy.

[12]  F. Baquero,et al.  Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli , 1991 .

[13]  É. Gay,et al.  Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States , 1990, Antimicrobial Agents and Chemotherapy.

[14]  G. Jacoby,et al.  Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases , 1990, Antimicrobial Agents and Chemotherapy.

[15]  W. Liu,et al.  Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents , 1990, Antimicrobial Agents and Chemotherapy.

[16]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[17]  H. Nikaido.  Outer membrane barrier as a mechanism of antimicrobial resistance , 1989, Antimicrobial Agents and Chemotherapy.

[18]  S. Mitsuhashi,et al.  Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli , 1989, Antimicrobial Agents and Chemotherapy.

[19]  G. Jacoby,et al.  beta-Lactamases and beta-lactam resistance in Escherichia coli , 1985, Antimicrobial Agents and Chemotherapy.

[20]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[21]  H. Nikaido,et al.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells , 1983, Journal of bacteriology.

[22]  S. Normark,et al.  Identification of a novel ampC beta‐lactamase promoter in a clinical isolate of Escherichia coli. , 1982, The EMBO journal.

[23]  T. Grundström,et al.  The E. coli β-lactamase attenuator mediates growth rate-dependent regulation , 1981, Nature.

[24]  S. T. Liu,et al.  Rapid procedure for detection and isolation of large and small plasmids , 1981, Journal of bacteriology.

[25]  C. Schmitges,et al.  The major proteins of the Escherichia coli outer cell-envelope membrane. Heterogeneity of protein I. , 1976, European journal of biochemistry.

[26]  R. Okamoto,et al.  Effects of r-Lactamases and omp Mutation on Susceptibility to 3-Lactam Antibiotics in Escherichia coli , 2022 .